scholarly journals Cell Proliferation in Esophageal Columnar Epithelium (Barrett’s Esophagus)

1978 ◽  
Vol 75 (4) ◽  
pp. 683-687 ◽  
Author(s):  
John J. Herbst ◽  
Malcolm M. Berenson ◽  
Donald W. McCloskey ◽  
W.C. Wiser
2021 ◽  
Vol 1 (1) ◽  
pp. 50-62
Author(s):  
Carmelo Scarpignato ◽  
David H. Wang

Gastro-esophageal reflux disease (GERD) and Barrett’s esophagus are risk factors for esophageal adenocarcinoma (EAC). Chemoprevention is an attractive strategy, more effective than identifying early disease. Since acid reflux can lead to increased cell proliferation, decreased apoptosis, production of reactive oxygen species, DNA damage, and esophageal production of proinflammatory and pro-proliferative cytokines, proton pump inhibitors (PPIs) alone, or in combination with COX-inhibition, are the most suitable chemopreventive agents. Other compounds (statins, metformin, and selected nutraceuticals) cannot currently be recommended. Data are strong enough to warrant PPI treatment of virtually all patients with Barrett’s esophagus, although the best regimen has not yet been defined.


Digestion ◽  
2004 ◽  
Vol 70 (2) ◽  
pp. 95-102 ◽  
Author(s):  
Hitoshi Nishigaki ◽  
Ken Wada ◽  
Atsushi Tatsuguchi ◽  
Nobuo Sueoka ◽  
Seiji Futagami ◽  
...  

2000 ◽  
Vol 278 (6) ◽  
pp. G1000-G1009 ◽  
Author(s):  
Baljeet S. Kaur ◽  
Rodica Ouatu-Lascar ◽  
M. Bishr Omary ◽  
George Triadafilopoulos

Barrett's esophagus (BE) results from acid and bile reflux and predisposes to cancer. We investigated the effect of bile salts, with or without acid, on cell proliferation in BE and assessed mechanism(s) involved. To mimic physiological conditions, biopsies of esophagus, BE, and duodenum were exposed to a bile salt mixture, either continuously or as a 1-h pulse, and were compared with control media without bile salts (pH 7.4) for ≤24 h. Similar experiments were also performed with acidified media (pH 3.5) combined with the bile salt mixture as a 1-h pulse. Cell proliferation was assessed by a [3H]thymidine incorporation assay with or without bisindolylmaleimide (BIM), a selective protein kinase C inhibitor. Bile salt pulses enhanced cell proliferation in BE without affecting cell proliferation in esophageal or duodenal epithelia. In the presence of BIM, there was complete obliteration of the bile salt-induced BE hyperproliferation. In contrast, 1-h pulses of bile salts in combination with acid significantly inhibited proliferation in BE but had no effect on esophagus or duodenum. We conclude that in BE explants, brief exposure to bile salts, in the absence of acid, increases proliferation, whereas exposure to a combination of bile salts and acid together inhibits proliferation.


1992 ◽  
Vol 103 (4) ◽  
pp. 1241-1245 ◽  
Author(s):  
Alan J. Cameron ◽  
Clifford T. Lomboy

2005 ◽  
Vol 100 (2) ◽  
pp. 499-499 ◽  
Author(s):  
Julio Rafael Mariano da Rocha ◽  
Ivan Cecconello ◽  
Ulysses Ribeiro ◽  
Joaquim Gama-Rodrigues

2015 ◽  
Vol 13 (4) ◽  
pp. 665-672.e4 ◽  
Author(s):  
Amitabh Chak ◽  
Navtej S. Buttar ◽  
Nathan R. Foster ◽  
Drew K. Seisler ◽  
Norman E. Marcon ◽  
...  

2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 5-5
Author(s):  
Sergio Szachnowicz ◽  
Andre Duarte ◽  
Edno Bianchi ◽  
Ary Nasi ◽  
Julio Mariano Rocha ◽  
...  

Abstract Background Background: Barrett’ s esophagus is a complication of severe gastroesophageal reflux disease. The major concern aspect is its association to dysplasia and esophageal adenocarcinoma. Endoscopic surveillance of patients treated surgically or clinically allows early detection of cancer. Aim: Compare clinical and surgical treatment of Barrett's esophagus. Methods Methods: from January 1980 to December 2017, 565 patients with Barrett's esophagus were followed up at our service. 214 were submitted to Nissen fundoplication and 221 to clinical treatment with PPI. These 434 patients were submitted to a long follow up with routine endoscopic examination each 2 years with multiple biopsies. The statistical analysis was performed through Fisher's exact test and Propensity score regarding epidemiologic and epithelium data. Results Comparing the surgical group (Group A) and the clinical group (Group B), we could observe the development of 11 Adenocarcinoma, 3 in the group A e 8 in group B. Any grade of dysplasia was observed in 9 patients of the group B, and six of them developed adenocarcinoma. The clinical group showed a tendency to develop more adenocarcioma and dysplasia than the surgical group (P = 0.38) and statistically significant increase in the development of dysplasia (P = 0032). 16% of patients in Group A showed progression in Columnar epithelium length against 20% in Group B (ns). 23,4% of the patients in group A keep symptoms and use of PPI, and 28.7 in group B (ns). Conclusion In our series as in many recent data in international literature, the surgical treatment for GERd in patients with Barrett's esophagus seems to be a good option to keep the columnar epithelium without progression to dysplasia or adenocarcinoma, with good control of the symptoms and the length of the Barrett's esophagus. Disclosure All authors have declared no conflicts of interest.


2008 ◽  
Vol 14 (21) ◽  
pp. 6988-6995 ◽  
Author(s):  
Dennis L. Chao ◽  
Carissa A. Sanchez ◽  
Patricia C. Galipeau ◽  
Patricia L. Blount ◽  
Thomas G. Paulson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document